Late in the 2016 U.S. Presidential primary, Donald Trump attacked Hillary Clinton for playing the “woman’s card.” Theories of system justification suggest that attitudes about gender, particularly endorsement of hostile and benevolent sexism, likely shaped reactions to this campaign attack. Using a set of two studies, we find that hostile sexists exposed to the attack showed increased support for Trump and decreased support for Clinton. Benevolent sexists, however, reacted to Trump’s statements with increased support for Clinton, consistent with benevolent sexism’s focus on protecting women (Study 1). We further found that the woman card attack produced distinct emotional reactions among those with low and high levels of hostile and benevolent sexism. The attack also increased political participation among hostile sexists (Study 2). Our results offer new insights into the role of sexism in the 2016 presidential contest and further the discipline’s understanding of the gendered dimension of negative campaigning.
In this article, we evaluate gender differences in COVID-19 conspiracy theory beliefs. We find that women are significantly less likely than men to endorse COVID-19 conspiracy theories and that this gender difference cuts across party lines. Our analysis suggests that this gender gap is partially explained by two dispositional factors: learned helplessness and conspiratorial thinking. Our findings qualify past work on the antecedents of conspiracy theory beliefs, which does not uncover robust and significant gender differences. The results highlight the need for work in this area to better theorize about the significance of gender.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.